Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 6/20 | 0.54 |
| ▸ | LOX | P28300 | 1/20 | 0.54 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.54 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25243547 | 0.97 | LOXL2 (0.52) | LOXL2LOXLOXL3PNMTHSP90AB1 | |
| SCHEMBL12291537 | 0.85 | LOXL2 (0.47) | LOXL2LOXLOXL3PNMTHSP90AB1 | |
| SCHEMBL16635420 | 0.84 | LOXL2 (0.45) | LOXL2LOXLOXL3PNMTHSP90AB1 | |
| SCHEMBL29714427 | 0.84 | LOX (0.45) | LOXL2LOXLOXL3PNMTHSP90AB1 | |
| SCHEMBL19755849 | 0.84 | LOX (0.45) | LOXL2LOXLOXL3PNMTHSP90AB1 | |
| SCHEMBL18050015 | 0.79 | LOXL2 (0.50) | LOXL2LOXLOXL3HSP90AB1KDM4E | |
| SCHEMBL190086 | 0.77 | RECQL (0.41) | LOXL2LOXLOXL3HSP90AB1S1PR2 | |
| SCHEMBL16635330 | 0.74 | LOXL2 (0.38) | LOXL2LOXLOXL3 | |
| Hydrochloric Acid SCHEMBL6869464 | 0.74 | RECQL (0.39) | LOXL2LOXLOXL3HSP90AB1S1PR2 | |
| SCHEMBL904515 | 0.72 | RECQL (0.54) | LOXL2LOXLOXL3HSP90AB1S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059185-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2025-02-20 | — | — | US | disclosed |
| EP-4448522-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023110958-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-06-22 | — | — | WO | disclosed |
| US-11236046-B2 | Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators | GENENTECH, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3313837-B1 | CARBOLINE ANTIPARASITICS | ZOETIS SERVICES LLC (US) | 2020-09-09 | — | — | EP | disclosed |
| US-10570129-B2 | Carboline antiparasitics | ZOETIS SERVICES LLC (US) | 2020-02-25 | — | — | US | disclosed |
| US-20200048197-A1 | SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | GENENTECH, INC. (US) | 2020-02-13 | — | — | US | disclosed |
| US-20200031822-A1 | CARBOLINE ANTIPARASITICS | ZOETIS SERVICES LLC (US) | 2020-01-30 | — | — | US | disclosed |
| EP-3256463-B1 | 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2019-10-09 | — | — | EP | disclosed |
| EP-3256463-B1 | 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2019-10-09 | — | — | EP | disclosed |
| WO-2008092942-A2 | PYRIDINYL-PYRAZOLE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | NEUROSEARCH A/S (DK) | 2008-08-07 | — | — | WO | disclosed |
| US-20080070902-A1 | Cinnamide Compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1757591-A1 | CINNAMIDE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006004062-A1 | 2,6-DICHLORO-4-PYRIDYLMETHYLAMINE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL DISEASE CONTROL AGENT | KUREHA CORPORATION (JP) | 2006-01-12 | — | — | WO | disclosed |
| US-20060004013-A1 | Alzheimer's disease, senile dementia, Down syndrome or amyloidosis; 3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one; imidazolyl-functional compounds inhibit production of Amyloid beta 40 and Amyloid beta 42; low hygroscopicity; good solubility | EISAI CO., LTD. | 2006-01-05 | — | — | US | disclosed |
| US-20050049285-A1 | Dichloropyridyl methyl cyanamidines | BAYER CROPSCIENCE AG (DE) | 2005-03-03 | — | — | US | disclosed |
| EP-1345494-A2 | DICHLOROPYRIDYL METHYLAMIDES | Bayer CropScience AG (DE) | 2003-09-24 | — | — | EP | disclosed |
| EP-1345904-A1 | DICHLOROPYRIDYL METHYL CYANAMIDINES | Bayer CropScience AG (DE) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002050037-A1 | DICHLOROPYRIDYL METHYL CYANAMIDINES | BAYER CROPSCIENCE AG (DE) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002050035-A2 | INSECTICIDAL AND FUNGICIDAL (2,6-DICHLORO-4-PYRIDYL) METHYLCARBAMATES USED AS PLANT PROTECTIVE AGENTS | BAYER CROPSCIENCE AG (DE) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059185-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | MGLL, LIPC, PNLIP | LOXL2 182/4885LOX 625/4885LOXL3 295/4885 |
| US-20200048197-A1 | SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | TRPA1, TRPV1, TRPV2 | LOXL2 2972/4885LOX 3601/4885LOXL3 3098/4885 |
| US-20080070902-A1 | Cinnamide Compound | C1S, CCR1, CNR1 | LOXL2 2773/4885LOX 3705/4885LOXL3 2457/4885 |
| US-10570129-B2 | Carboline antiparasitics | ADRA1D, DRD1, CHRM1 | LOXL2 2959/4885LOX 4048/4885LOXL3 1979/4885 |
| US-11236046-B2 | Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators | TRPA1, TRPV1, TRPV2 | LOXL2 2972/4885LOX 3601/4885LOXL3 3098/4885 |
| US-20200031822-A1 | CARBOLINE ANTIPARASITICS | DRD1, ADRA1D, DRD2 | LOXL2 3401/4885LOX 4239/4885LOXL3 2504/4885 |
| US-20050049285-A1 | Dichloropyridyl methyl cyanamidines | MRPL21, DDT, FBL | LOXL2 1670/4885LOX 3461/4885LOXL3 2191/4885 |
| US-20060004013-A1 | Alzheimer's disease, senile dementia, Down syndrome or amyloidosis; 3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one; imidazolyl-functional compounds inhibit production of Amyloid beta 40 and Amyloid beta 42; low hygroscopicity; good solubility | PSEN1, APP, BACE1 | LOXL2 4523/4885LOX 4279/4885LOXL3 4696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.